Gameto raised $44 million to develop engineered ovarian cell lines that mimic natural ovarian function, targeting rare reproductive disorders like accelerated ovarian aging.
Gameto raised $44 million to develop engineered ovarian cell lines that mimic natural ovarian function, targeting rare reproductive disorders like accelerated ovarian aging.
